These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16388880)

  • 21. Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine.
    Luo F; Liao FL; Wang H; Tang HB; Yang ZQ; Hou W
    Virol Sin; 2018 Apr; 33(2):201-204. PubMed ID: 29541941
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
    Cavanagh D
    Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.
    Takasuka N; Fujii H; Takahashi Y; Kasai M; Morikawa S; Itamura S; Ishii K; Sakaguchi M; Ohnishi K; Ohshima M; Hashimoto S; Odagiri T; Tashiro M; Yoshikura H; Takemori T; Tsunetsugu-Yokota Y
    Int Immunol; 2004 Oct; 16(10):1423-30. PubMed ID: 15314040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry.
    He Y; Zhou Y; Siddiqui P; Jiang S
    Biochem Biophys Res Commun; 2004 Dec; 325(2):445-52. PubMed ID: 15530413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
    He Y; Zhu Q; Liu S; Zhou Y; Yang B; Li J; Jiang S
    Virology; 2005 Mar; 334(1):74-82. PubMed ID: 15749124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.
    Bolles M; Deming D; Long K; Agnihothram S; Whitmore A; Ferris M; Funkhouser W; Gralinski L; Totura A; Heise M; Baric RS
    J Virol; 2011 Dec; 85(23):12201-15. PubMed ID: 21937658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques.
    Yang J; Huo X; Jiang Q; Liao Y; Zhang C; Yu L; Wang Q; Niu T; Li C; Pi N; Li Y; Zhao H; Zhang Y; Tan Y; Liao W; Li Y; Fan S; Li Q
    Vaccine; 2023 Apr; 41(17):2837-2845. PubMed ID: 37003910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV.
    Gai WW; Zhang Y; Zhou DH; Chen YQ; Yang JY; Yan HM
    Virol Sin; 2011 Apr; 26(2):81-94. PubMed ID: 21468931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
    Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody.
    Wang X; Ni B; Du X; Zhao G; Gao W; Shi X; Zhang S; Zhang L; Wang D; Luo D; Xing L; Jiang H; Li W; Jiang M; Mao L; He Y; Xiao Y; Wu Y
    Antivir Ther; 2005; 10(5):681-90. PubMed ID: 16152762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine.
    Pang H; Liu Y; Han X; Xu Y; Jiang F; Wu D; Kong X; Bartlam M; Rao Z
    J Gen Virol; 2004 Oct; 85(Pt 10):3109-3113. PubMed ID: 15448374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study.
    Abdoli A; Aalizadeh R; Aminianfar H; Kianmehr Z; Teimoori A; Azimi E; Emamipour N; Eghtedardoost M; Siavashi V; Jamshidi H; Hosseinpour M; Taqavian M; Jalili H
    Rev Med Virol; 2022 May; 32(3):e2305. PubMed ID: 34699647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies.
    Kuate S; Cinatl J; Doerr HW; Uberla K
    Virology; 2007 May; 362(1):26-37. PubMed ID: 17258782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
    Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
    Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
    Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N
    J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.
    Fett C; DeDiego ML; Regla-Nava JA; Enjuanes L; Perlman S
    J Virol; 2013 Jun; 87(12):6551-9. PubMed ID: 23576515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single B cells reveal the antibody responses of rhesus macaques immunized with an inactivated enterovirus D68 vaccine.
    Zheng H; Yang Z; Li B; Li H; Guo L; Song J; Hou D; Li N; Yang J; Wu Q; Sun M; Liu L
    Arch Virol; 2020 Aug; 165(8):1777-1789. PubMed ID: 32462286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.
    Lv H; Wu NC; Tsang OT; Yuan M; Perera RAPM; Leung WS; So RTY; Chan JMC; Yip GK; Chik TSH; Wang Y; Choi CYC; Lin Y; Ng WW; Zhao J; Poon LLM; Peiris JSM; Wilson IA; Mok CKP
    Cell Rep; 2020 Jun; 31(9):107725. PubMed ID: 32426212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.